Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Small cap snapshot: Globex Mining, NanoViricides, CULT Food Science, Revive Therapeutics, SWMBRD, Lumina Gold UPDATE...

Atossa Therapeutics Inc (NASDAQ:ATOS), which is developing medicines aimed at oncology and breast cancer, announced a sponsored research agreement with Weill Cornell Medicine to address treatment challenges in triple negative breast cancer (TNBC).

The Seattle-based clinical-stage biopharma company said the aim is to determine if treating TNBC with extracellular vesicles carrying the estrogen receptor (ER) will convert the tumor to ER+ and render it sensitive to treatment with Selective Estrogen Receptor Modulators (SERM), including Atossa’s own (Z)-endoxifen.

Read more

American Rare Earths Ltd (ASX:ARR, OTCQB:ARRNF) has revealed a new method to extract rare earth elements in a more cost-effective and sustainable manner.

The company is hoping to put the method to use at its flagship Halleck Creek project in Wyoming, which houses a total of 1.46 billion tons of rare earth minerals, including key magnet metals like neodymium and praseodymium.

Read more

Phunware Inc (NASDAQ:PHUN) has announced that its Smart Hospitality Solution is being released at the Thumper Pond Resort in Minnesota.

Key features of the solution include a mobile app for iOS and Android devices, contextual engagement allowing guests to receive location and preference based-notifications, and location-based services to enable guests to easily navigate the resort, the company said.

Read more

NanoViricides Inc (NYSE-A:NNVC) has announced that the clinical trial of its broad-spectrum antiviral drug, NV-CoV-2, is progressing satisfactorily. The drug is being developed as a potential treatment for coronavirus infections, including COVID-19 and long COVID.

The ongoing Phase 1a trial involves evaluating the safety and tolerability of NV-CoV-2 in healthy individuals who received escalating doses of the drug in oral syrup or gummy form. So far, there have been no serious adverse events reported at any dose level, including the highest dosages.

Read more

European Lithium Ltd (ASX:EUR, OTCQB:EULIF) has announced that Critical Metals Corp has signed a share subscription facility worth up to US$125 million with GEM Global Yield LLC SCS.

The facility will provide transaction funding to accelerate the development of the Wolfsberg Lithium Project in Austria.

Read more

To enhance its position in the rare earths industry and expand its footprint in the US, including a proposed Nasdaq listing, American Rare Earths Ltd (ASX:ARR, OTCQB:ARRNF) will make key appointments to its leadership team, including adding new directors and establishing a Denver-based management team.

A new chief executive officer and chief financial officer will be appointed to the US team, and together with ARR’s North America president Mel Sanderson, will drive commercialisation efforts, conduct feasibility studies and oversee exploration activities in Wyoming, Arizona and Montana.

Read more

Endeavour Mining PLC has said it will release its Q2 and half year 2023 financial results on Wednesday August 2, before the LSE market open. Management will host a conference call and webcast on the same day, Wednesday 2 August, at 8.30am EDT / 1,30pm BST to discuss the financial results. The webcast can be accessed through the following link: https://edge.media-server.com/mmc/p/52ikoagj. Analysts and investors are also invited to participate and ask questions by registering for the conference call via the following link: https://register.vevent.com/register/BI146a3a0f027c43aba052fb62c488fdc6.

PharmaDrug Inc said it has reached an agreement with the holders of $650,000 principal amount of the company’s convertible debentures to terminate a general security agreement granted by the company’s wholly-owned subsidiary Sairiyo Therapeutics Inc. As consideration for agreeing to terminate the general security agreement the company has agreed to issue an aggregate of five million of its common shares in to the debt holders. The termination of this general security agreement is being completed in conjunction with a proposed strategic investment by an arm's length third party in Sairiyo.

Silver Bullet Mines Corp announced that John MacKenzie has resigned from its board of directors, effective June 30. The company thanked MacKenzie for his contribution and wishes him success in all future endeavours. The compamny said its board is actively engaged in identifying and evaluating alternatives with respect to the appointment of a new director to fill the vacancy left by MacKenzie.

Tribe Property Technologies Inc has announced the results of voting at its July 5, 2023 annual general and special meeting, at which the company's shareholders approved resolutions to elect directors, appoint auditors, and re-approve the company's stock option plan. Shareholders re-elected Joseph Nakhla, Raymond Choy, Charmaine Crooks, Andrew Kiguel, Michael Willis, and Sanjiv Samant as directors of the company to hold office until the date of the next annual meeting of shareholders or until their successors are elected or appointed. Shareholders also appointed Dale Matheson Carr-Hilton LaBonte LLP as auditor of the company for the ensuing year and the directors were authorized to fix the remuneration to be paid to the auditor.

Banxa Holdings Inc. has successfully had its cease trade order revoked by the British Columbia Securities Commission and the Ontario Securities Commission. The company has applied to the TSX Venture Exchange to reinstate trading of its common shares. The annual general meeting of shareholders has been postponed to a date before September 28, 2023, with an undertaking to hold the meeting within three months after June 30, 2023. Additionally, Sean Moynihan has been appointed as Chief Financial Officer, effective January 2, 2023.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK